botulinum toxin strain Archives

Medytox’s Patent Suit Against Daewoong Dismissed in U.S.

SEOUL, Oct. 7 (Korea Bizwire) — A U.S. court accepted a motion to dismiss a patent suit by South Korean drugmaker Medytox Inc. against its local rival Daewoong Pharmaceutical Co. over a botulinum toxin strain, company officials here said Thursday. Medytox had sued Daewoong in the Eastern District Court of Virginia and the Central District [...]

ITC Favors Medytox over Daewoong in Botulinum Toxin Strain Dispute

SEOUL, July 7 (Korea Bizwire) — The U.S. International Trade Commission (ITC) has sided with South Korean drugmaker Medytox Inc. in a trade dispute, saying its local rival Daewoong Pharmaceutical Co. stole secrets on a botulinum toxin strain, industry officials here said Tuesday. In its preliminary verdict, a U.S. trade judge on Monday (U.S. time) [...]